Navigation Links
Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
Date:8/9/2011

ARDEN HILLS, Minnesota, August 9, 2011 /PRNewswire/ --

 

- Cryotherapy Continues to Grow as the Treatment of Choice for Renal Tumors Around the World

Galil Medical, a global leader in minimally invasive cryotherapy treatments, announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved reimbursement for small renal cancer cryoablation using a percutaneous approach, as well as under open or endoscopic surgery.

 "We appreciate the MHLW reimbursement decision as this will allow Japanese patients to have greater access to renal cryoablation and benefit from Galil's advanced technology," commented Martin Emerson, Galil Medical President and CEO.

Galil Medical's CryoHit/SeedNet for MRI received approval for small renal tumor cryoablation under MRI-guidance in January 2010 from the MHLW. The regulatory and reimbursement approval processes have been spearheaded by Hitachi Medical Corporation, Galil Medical's exclusive distribution partner in Japan.

Cryotherapy is a minimally invasive procedure that uses extreme cold to freeze and destroy tumors. Visualization with MR imaging monitors the ablation zone of the tumor and minimizes impact to healthy adjacent tissue.

Standard treatment options for renal cancer include total and partial nephrectomy, open and laparoscopic procedures.  Minimally invasive ablative therapies, such as percutaneous cryotherapy, are increasingly accepted treatment options due to favorable clinical outcomes, reduced procedural pain, fewer complications and faster patient recovery. 

About Galil Medical Galil Medical is a global leader in delivering innovative cryotherapy solutions. The company is addressing patient conditions across multiple physician specialties; treatment areas include conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve applications. Company offices are located in Arden Hills, Minnesota; Yokneam, Israel; and London, United Kingdom. Shareholders include Thomas, McNerney & Partners, The Vertical Group, and Investor Growth Capital.

Contact information:

Pam Schwartz
Asia Pacific Manager
Galil Medical
T: +972-4-909-3273
M: +972-52-625-4443
F: +972-4-959-1077
pam.schwartz@galilmedical.com

Lisa Hayden
Vice President, Global Reimbursement
Galil Medical
T: +1-877-639-2796 option #4
M: +1-703-209-7774
F: +1-651-287-5125
lisa.hayden@galilmedical.com



'/>"/>
SOURCE Galil Medical Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Galil Medical Announces Establishment of Global Headquarters in Minneapolis, MN
2. Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
3. Healthcare Practices Considering Outsourcing Their Medical Typing Requirements - Med Data Care Pro, an Ideal Choice
4. Carrot Medical Positioned for Third Straight Year of Triple Digit Growth
5. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
6. Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey
7. Researchers Find RapidArc® Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
8. China Medical Technologies and Leica Microsystems Announce Collaboration
9. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
10. South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems
11. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Feb 27, 2017 Period October – December 2016 ... Operating result amounted to SEK -16.4 (-6.4) million Result after ... (-0.22) before and after dilution Cash flow from operating activities ... ... 0.4 (0.4) million Operating result amounted to SEK -39.5 (-29.5) ...
(Date:2/24/2017)... , Feb. 24, 2017 Research and ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... a CAGR of around 23.8% over the next decade to reach ... the market estimates and forecasts for all the given segments on ...
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies ... eye market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Dry eye ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... 26, 2017 , ... Today, A' Design Awards & Competition ... Social Design Awards. , The 7th A' Social Design Award is open ... worldwide with realized projects and conceptual works. , The first phase of the ...
(Date:2/26/2017)... , ... February 26, 2017 ... ... a new technology standard in staffing, scheduling, and reporting for healthcare organizations. ... predict activity throughout the entire staffing process. StaffBridge technology improves staffing efficiency, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Liberty University, has officially announced the appointment of Peter A. Bell, DO, MBA, ... Osteopathic Medicine (LUCOM), beginning April 10. Dr. Bell comes to Liberty from ...
(Date:2/24/2017)... ... 2017 , ... The narrative in “ Signal 8: An Australian Paramedic’s Story ... his paramedic experiences. Schanssema describes the tragedies he saw, as well as his struggles ... , Schanssema, initially unsure of the career path he wanted to take, found fulfillment ...
Breaking Medicine News(10 mins):